Help - Search - Members - Calendar
Full Version: Heart-Failure
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Cardiology > Heart-Failure
Pages: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
  1. Heart-Failure: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure (0 replies)
  2. Heart-Failure: Sign publishes guideline on the management of chronic heart failure – sign 95 (0 replies)
  3. Heart-Failure: Ventilatory response during exercise among chronic chagas cardiopathy patients. (0 replies)
  4. Heart-Failure: What do the newer inotropic drugs have to offer? (0 replies)
  5. Heart-Failure: Reproducibility of onset and recovery oxygen uptake kinetics in moderately impaired patients with chronic heart failure (0 replies)
  6. Heart-Failure: Innovative crts track heart patients progress from home (0 replies)
  7. Heart-Failure: Innovative crts track heart patients progress from home (0 replies)
  8. Heart-Failure: Original heart failure diagnoses in proactive study confirmed. (0 replies)
  9. Heart-Failure: Original heart failure diagnoses in proactive study confirmed. (0 replies)
  10. Heart-Failure: The 6-min walk test: a useful test in elderly patients with heart failure? (0 replies)
  11. Heart-Failure: The 6-min walk test: a useful test in elderly patients with heart failure? (0 replies)
  12. Heart-Failure: The prognostic value of ventilatory efficiency with beta-blocker therapy in heart failure. (0 replies)
  13. Heart-Failure: An uncommon cause of heart failure (0 replies)
  14. Heart-Failure: Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failurefranciosa ja: fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart (0 replies)
  15. Heart-Failure: Drug discovery for heart failure: a new era or the end of the pipeline? (0 replies)
  16. Heart-Failure: β-blocker therapy of heart failure: an update (0 replies)
  17. Heart-Failure: Neuronal imaging using spect (0 replies)
  18. Heart-Failure: Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: beneficial effects of mineralocorticoid receptor blocker (0 replies)
  19. Heart-Failure: Sex-based differences in myocardial contractile reserve (0 replies)
  20. Heart-Failure: Diagnostic and therapeutic approach to acute decompensated heart failure. (0 replies)
  21. Heart-Failure: Acute heart failure associated with venlafaxine poisoning. (0 replies)
  22. Heart-Failure: Age-related role of ambulatory electrocardiographic monitoring in risk stratification of patients with complete congenital atrioventricular block (0 replies)
  23. Heart-Failure: N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity. (0 replies)
  24. Heart-Failure: Abnormal response of left ventricular systolic function to submaximal exercise in post-partial left ventriculotomy patients. (0 replies)
  25. Heart-Failure: How prostacyclin improves cardiac output in acute right heart failure on pulmonary hypertension. (0 replies)
  26. Heart-Failure: Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. (0 replies)
  27. Heart-Failure: Innovative crts track heart patients progress from home (0 replies)
  28. Heart-Failure: Nonlinear indices of heart rate variability in chronic heart failure patients: redundancy and comparative clinical value (0 replies)
  29. Heart-Failure: Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice (0 replies)
  30. Heart-Failure: The autonomic nervous system at high altitude (0 replies)
  31. Heart-Failure: [letters to the editor] corcap device in addition to mitral surgery in heart failure: is it truly beneficial? (0 replies)
  32. Heart-Failure: [cardiopulmonary support and physiology] vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device (0 replies)
  33. Heart-Failure: Patient views of social service provision for older people with advanced heart failure (0 replies)
  34. Heart-Failure: New test is immediately useful in diagnosing heart failure, reports the harvard men's health watch (0 replies)
  35. Heart-Failure: New test is immediately useful in diagnosing heart failure, reports the harvard men's health watch (0 replies)
  36. Heart-Failure: Pediatric ventricular assist devices (0 replies)
  37. Heart-Failure: [therapeutics] diuretics were superior to calcium channel blockers and short term ace inhibitors for reducing heart failure in hypertension (0 replies)
  38. Heart-Failure: Highlights of the 2006 scientific sessions of the heart failure society of america: seattle, washington, september 10-13, 2006 (0 replies)
  39. Heart-Failure: Relationship between c-reactive protein levels and regional left ventricular function in asymptomatic individuals: the multi-ethnic study of atherosclerosis (0 replies)
  40. Heart-Failure: Long-term clinical variation of nt-probnp in stable chronic heart failure patients (0 replies)
  41. Heart-Failure: Telomere length is associated with left ventricular function in the oldest old: the newcastle 85+ study (0 replies)
  42. Heart-Failure: All medicare prescription drug plans should be required to cover heart medication bidil for black beneficiaries, according to naacp letter (0 replies)
  43. Heart-Failure: All medicare prescription drug plans should be required to cover heart medication bidil for black beneficiaries, according to naacp letter (0 replies)
  44. Heart-Failure: New test is immediately useful in diagnosing heart failure (0 replies)
  45. Heart-Failure: New test is immediately useful in diagnosing heart failure (0 replies)
  46. Heart-Failure: Astellas terminates agreement on acute heart failure agent carperitide (0 replies)
  47. Heart-Failure: Astellas terminates agreement on acute heart failure agent carperitide (0 replies)
  48. Heart-Failure: Valley baptist ranks no. 1 in heart-failure treatment (0 replies)
  49. Heart-Failure: Christ hospital opens heart center (0 replies)
  50. Heart-Failure: Myocardium doesn't suffer from cpap-related lvef gains in hf patients with sleep apnea (0 replies)
  51. Heart-Failure: [endocrinology and metabolism] circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay (0 replies)
  52. Heart-Failure: Heart failure and a controlled trial investigating outcomes of exercise training (hf-action): design and rationale. (0 replies)
  53. Heart-Failure: Improvement of chronic heart failure by dexamethasone is not associated with downregulation of leptin in rats. (0 replies)
  54. Heart-Failure: Levosimedan for pediatric patients with refractory heart failure to the conventional treatment. (0 replies)
  55. Heart-Failure: New international study to test exercise in heart failure patients (0 replies)
  56. Heart-Failure: New international study to test exercise in heart failure patients (0 replies)
  57. Heart-Failure: Natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. (0 replies)
  58. Heart-Failure: Natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. (0 replies)
  59. Heart-Failure: Effects of hydroxyethyl starch administration on renal function in critically ill patients (0 replies)
  60. Heart-Failure: Hot topic: how much is too much? moderate alcohol consumption is not a risk factor for heart failure (0 replies)
  61. Heart-Failure: Sponsorship Opportunity (0 replies)
  62. Heart-Failure: The physiological significance of the alternative pathways of angiotensin ii production. (0 replies)
  63. Heart-Failure: Lipopolysaccharide activates calcineurin in ventricular myocytes (0 replies)
  64. Heart-Failure: Continuous positive airway pressure and increased ejection fraction in heart failure and obstructive sleep apnea: is there a metabolic cost or benefit? (0 replies)
  65. Heart-Failure: The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea (0 replies)
  66. Heart-Failure: [electronic case studies] airway compression by major aortopulmonary collaterals with 22q11 deletion (0 replies)
  67. Heart-Failure: [electronic case studies] primary malignant fibrous histiocytoma of the heart (0 replies)
  68. Heart-Failure: Nt-probnp correlates not only with ejection fraction, but also with inferior vena cava diameter in patients with acute heart failure. (0 replies)
  69. Heart-Failure: B-type natriuretic peptide testing is associated with reduced cost in patients with secondary diagnosis of heart failure. (0 replies)
  70. Heart-Failure: Necrotic death without mitochondrial dysfunction-delayed death of cardiac myocytes following oxidative stress. (0 replies)
  71. Heart-Failure: Bridge to transplantation with a left ventricular assist device for systemic ventricular failure after mustard procedure. (0 replies)
  72. Heart-Failure: Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices. (0 replies)
  73. Heart-Failure: [mechanical cardiac assistance and artificial heart: historical perspectives] (0 replies)
  74. Heart-Failure: See your message here (0 replies)
  75. Heart-Failure: Use of disease-modifying therapies in patients hospitalized with heart failure: a population-based perspective. (0 replies)
  76. Heart-Failure: Beyond diuretics: management of volume overload in acute heart failure syndromes. (0 replies)
  77. Heart-Failure: Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. (0 replies)
  78. Heart-Failure: Practical applications of intravenous diuretic therapy in decompensated heart failure. (0 replies)
  79. Heart-Failure: Pathophysiology of volume overload in acute heart failure syndromes. (0 replies)
  80. Heart-Failure: Aldosterone blockade: an emerging strategy for abrogating progressive renal disease. (0 replies)
  81. Heart-Failure: See your message here (0 replies)
  82. Heart-Failure: Sponsorship Opportunity (0 replies)
  83. Heart-Failure: Sponsorship Opportunity (0 replies)
  84. Heart-Failure: Significance of asymmetric basal posterior wall thinning in patients with cardiac fabry's disease. (0 replies)
  85. Heart-Failure: Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives. (0 replies)
  86. Heart-Failure: Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure. (0 replies)
  87. Heart-Failure: Comparison of multidetector computed tomography and two-dimensional transthoracic echocardiography for left ventricular assessment in patients with heart failure. (0 replies)
  88. Heart-Failure: Usefulness of preimplantation b-type natriuretic peptide level for predicting response to cardiac resynchronization therapy. (0 replies)
  89. Heart-Failure: Sponsorship Opportunity (0 replies)
  90. Heart-Failure: Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients. (0 replies)
  91. Heart-Failure: Contribution of right-sided heart enlargement to cardiomegaly on chest roentgenogram in diastolic and systolic heart failure. (0 replies)
  92. Heart-Failure: Relation of heart rate turbulence to severity of heart failure. (0 replies)
  93. Heart-Failure: Unusual complications of coronary artery bypass graft surgery. (0 replies)
  94. Heart-Failure: Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. (0 replies)
  95. Heart-Failure: Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure. (0 replies)
  96. Heart-Failure: The apelin/apj system: from vascular biology to heart failure. (0 replies)
  97. Heart-Failure: Role of the renin-angiotensin-aldosterone system in diastolic heart failure: potential for pharmacologic intervention. (0 replies)
  98. Heart-Failure: Cardiopulmonary interactions in patients with heart failure. (0 replies)
  99. Heart-Failure: Maintaining hope in transition: a theoretical framework to guide interventions for people with heart failure. (0 replies)
  100. Heart-Failure: Psychological factors and treatment adherence behavior in patients with chronic heart failure. (0 replies)
  101. Heart-Failure: See your message here (0 replies)
  102. Heart-Failure: Antithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implications (0 replies)
  103. Heart-Failure: Pediatric heart failure,. (0 replies)
  104. Heart-Failure: Sponsorship Opportunity (0 replies)
  105. Heart-Failure: Glucose level upon admission for heart failure. (0 replies)
  106. Heart-Failure: Standardizing and predicting results from cardiopulmonary exercise testing in patients with heart failure. (0 replies)
  107. Heart-Failure: Adenosine a1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure. (0 replies)
  108. Heart-Failure: Therapeutic effects of angiotensin ii type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure. (0 replies)
  109. Heart-Failure: The evolving care of the elderly with heart failure: from the 'high-tech' to the 'high-touch' approach. (0 replies)
  110. Heart-Failure: Bidil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients. (0 replies)
  111. Heart-Failure: Sponsorship Opportunity (0 replies)
  112. Heart-Failure: First use of the tandemheart percutaneous left ventricular assist device as a short-term bridge to cardiac transplantation. (0 replies)
  113. Heart-Failure: Adjudication of serious heart failure in patients from proactive. (0 replies)
  114. Heart-Failure: Obesity may reduce risk of heart failure death
    (reuters)     (0 replies)
  115. Heart-Failure: Sponsorship Opportunity (0 replies)
  116. Heart-Failure: Obesity may reduce risk of heart failure death (0 replies)
  117. Heart-Failure: Is exercise really good for heart failure patients? (0 replies)
  118. Heart-Failure: Sponsorship Opportunity (0 replies)
  119. Heart-Failure: Sponsorship Opportunity (0 replies)
  120. Heart-Failure: Nitric oxide and peroxynitrite in health and disease (0 replies)
  121. Heart-Failure: Cardiac-specific overexpression of e40k active akt prevents pressure overload-induced heart failure in mice by increasing angiogenesis and reducing apoptosis (0 replies)
  122. Heart-Failure: Sponsorship Opportunity (0 replies)
  123. Heart-Failure: New international study to test exercise in heart failure patients (0 replies)
  124. Heart-Failure: Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis (0 replies)
  125. Heart-Failure: A long-term "memory" of hif induction in response to chronic mild decreased oxygen after oxygen normalization (0 replies)
  126. Heart-Failure: See your message here (0 replies)
  127. Heart-Failure: Ochsner undergoing clinical study to evaluate first-in-class cardiac device (0 replies)
  128. Heart-Failure: Ochsner undergoing clinical study to evaluate first-in-class cardiac device (0 replies)
  129. Heart-Failure: The top medical stories of 2006 (0 replies)
  130. Heart-Failure: [heart reviews] heart failure with a normal ejection fraction (0 replies)
  131. Heart-Failure: Sponsorship Opportunity (0 replies)
  132. Heart-Failure: Peak oxygen consumption and heart failure prognosis in women (0 replies)
  133. Heart-Failure: Sponsorship Opportunity (0 replies)
  134. Heart-Failure: Evidence of left ventricular dyssynchrony resulting from right ventricular pacing in patients with severely depressed left ventricular ejection fraction (0 replies)
  135. Heart-Failure: Left ventricular electromechanical delay in patients with heart failure and normal qrs duration and in patients with right and left bundle branch block (0 replies)
  136. Heart-Failure: Sponsorship Opportunity (0 replies)
  137. Heart-Failure: Sponsorship Opportunity (0 replies)
  138. Heart-Failure: Asthma: stoplight tools for patients (0 replies)
  139. Heart-Failure: Chronic heart failure: stoplight tools for patients (0 replies)
  140. Heart-Failure: Diabetes: stoplight tools for patients (0 replies)
  141. Heart-Failure: Sponsorship Opportunity (0 replies)
  142. Heart-Failure: Surgery improves survival in patients with heart failure (0 replies)
  143. Heart-Failure: University of texas at austin nursing researcher conducts healthy heart study (0 replies)
  144. Heart-Failure: Surgery improves survival in patients with heart failure (0 replies)
  145. Heart-Failure: Success in treating heart failure (0 replies)
  146. Heart-Failure: University of texas at austin nursing researcher conducts healthy heart study (0 replies)
  147. Heart-Failure: Success in treating heart failure (0 replies)
  148. Heart-Failure: Sponsorship Opportunity (0 replies)
  149. Heart-Failure: [determination of functional capacity in heart failure] (0 replies)
  150. Heart-Failure: [cut-off values of bnp and nt-bnp for diagnosis of heart failure in emergency service] (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2009 Invision Power Services, Inc.